Brief: DMK Pharmaceuticals Got Notice From Nasdaq Saying It Is Not In Compliance With Minimum Bid Price Requirements
10/10/2023 13:05
Oct 10 (Reuters) - DMK Pharmaceuticals Corp DMK.O :
* DMK PHARMACEUTICALS CORP - ON OCTOBER 4, GOT NOTICE FROM
NASDAQ
NOTIFYING CO THAT IT IS NOT IN COMPLIANCE WITH MINIMUM BID PRICE
REQUIREMENTS
Source text for Eikon: ID:
Further company coverage: DMK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DMK Pharmaceuticals
See all newsBrief: Dmk Pharmaceuticals Corp Says Ebrahim Versi Resigned As Chairman
Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
Brief: DMK Pharmaceuticals Regains Full Rights From US Worldmeds For Symjepi And Provides Corporate Update